Chemoinformaics analysis of 1,5-DIHYDROXYXANTHEN-9-ONE
| Molecular Weight | 228.203 | nRot | 0 |
| Heavy Atom Molecular Weight | 220.139 | nRig | 24 |
| Exact Molecular Weight | 228.042 | nRing | 3 |
| Solubility: LogS | -2.417 | nHRing | 1 |
| Solubility: LogP | 6.057 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 16 |
| nHA | 4 | APOL | 30.2523 |
| nHD | 2 | BPOL | 10.6297 |
| QED | 0.366 |
| Synth | 3.275 |
| Natural Product Likeliness | 2.64 |
| NR-PPAR-gamma | 0.895 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.996 |
| Pgp-sub | 0.001 |
| HIA | 0.137 |
| CACO-2 | -4.797 |
| MDCK | 0.0000141 |
| BBB | 0.002 |
| PPB | 0.940096 |
| VDSS | 0.558 |
| FU | 0.0795312 |
| CYP1A2-inh | 0.409 |
| CYP1A2-sub | 0.3 |
| CYP2c19-inh | 0.741 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.878 |
| CYP2c9-sub | 0.869 |
| CYP2d6-inh | 0.39 |
| CYP2d6-sub | 0.209 |
| CYP3a4-inh | 0.246 |
| CYP3a4-sub | 0.123 |
| CL | 3.433 |
| T12 | 0.441 |
| hERG | 0.01 |
| Ames | 0.242 |
| ROA | 0.885 |
| SkinSen | 0.788 |
| Carcinogencity | 0.545 |
| EI | 0.48 |
| Respiratory | 0.379 |
| NR-Aromatase | 0.944 |
| Antiviral | Yes |
| Prediction | 0.622142 |